| Haber: |
Haber Kaynağı: Çeşitli Haber Siteleri
STAT+: Pharmalittle: U.S. government blunder contributed to monkeypox vax shortage; Amgen to pay $4 billion for ChemoCentryx
Amgen will acquire ChemoCentryx for $4 billion to obtain a newly approved medicine that treats patients with a serious autoimmune condition.
https://www.statnews.com/pharmalot/2022/08/04/covid19-monkeypox-vaccine-medicaid-amgen-insulin-layoffs-opioids/?utm_campaign=rss
|
